SEC 13F Intelligence

Boxer Capital Management, LLC / AMLX

Boxer Capital Management, LLC’s Amylyx Pharmaceuticals Inc Position

Does Boxer Capital Management, LLC own Amylyx Pharmaceuticals Inc (AMLX)? Yes — 800.0K shares worth $11M (+1.46% of its 13F portfolio) as of Q1 2026.

Position Value
$11M
Q1 2026
Shares
800.0K
% of Portfolio
+1.46%
Quarters Held
6
currently held

Position History AMLX

Reported value by quarter
Q4 ’24: $7MQ4 ’24Q1 ’25: $6MQ1 ’25Q2 ’25: $8MQ2 ’25Q3 ’25: $12MQ3 ’25Q4 ’25: $10MQ4 ’25Q1 ’26: $11MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026800.0K$11M+1.46%
Q4 2025800.0K$10M+2.12%
Q3 2025900.0K$12M+3.90%
Q2 20251.23M$8M+3.95%
Q1 20251.75M$6M+1.86%
Q4 20241.75M$7M+0.56%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital Management, LLC’s full portfolio or all institutional holders of AMLX.